Last reviewed · How we verify

NCT02585063

Independent Prescribing Optometrists in Acute Ophthalmic Services

Completed Last updated 14 January 2021
What this trial tests

trial in Eye Abnormalities in 321 participants. Completed in 12 September 2018.

Timeline
1 December 2015
Primary endpoint
13 December 2017
12 September 2018

Quick facts

Lead sponsorAston University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment321
Start date1 December 2015
Primary completion13 December 2017
Estimated completion12 September 2018
Sites1 location across United Kingdom

Conditions studied

Sponsor

Aston University

Who can join

18 and older, any sex, with Eye Abnormalities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The UK government's Crown report titled 'Review of prescribing, supply \& administration of medicines' enabled optometrists to train for the qualification of independent prescribing (IP). The UK introduced IP for optometrists in 2009. The proposed research focuses on the role of IP optometrist in the acute ophthalmic services of Manchester Royal Eye Hospital (MREH). The study will compare IP optometrists to consultant ophthalmologists in the ability to diagnose, manage and prescribe medication for patients accessing these services. To achieve this comparison consenting participants will first have a clinical assessment with the IP Optometrist, where findings including diagnosis and management plan will be recorded onto a research proforma. The consultant ophthalmologist will be masked to the IP Optometrist's research proforma to prevent bias. The consultant ophthalmologist will then perform a clinical assessment on a second proforma and inform the participant of their diagnosis and management plan. Percentage agreement, kappa (κ) and weighted κ will be calculated for a range of parameters between the two proformas. Disagreement in diagnosis or management will be arbitrated by a separate ophthalmologist participating in the study with a specialty relevant to the participant's condition. The main objective of the research is to expand the limited base of evidence of of IP optometrists' ability to diagnose, manage and prescribe medication and to determine whether they work at least as safely and effectively as consultant ophthalmologists in acute ophthalmic services. It is the first study in this area since the advent of IP for optometrists, with only one previous study published before IP was introduced. The research will enable the type and frequency of conditions presenting in these services to be measured. Furthermore it will identify conditions that IP optometrists can manage independently and enable guidelines for these conditions to be developed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Agreement in clinical decision-making between independent prescribing optometrists and consultant ophthalmologists in an emergency eye department.
    Todd D, Bartlett H, Thampy R, Dhawahir-Scala F, et al · · 2020 · cited 11× · PMID 32203243 · DOI 10.1038/s41433-020-0839-7

Verify or expand the search:

Other recruiting trials for Eye Abnormalities

Currently open trials in the same condition.

Other Aston University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02585063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing